Search | Leading Edge Only

Published

Healthcare & Pharmaceuticals

Modulators of Class IIa HDACs

UQ has exploited structural differences between Class I and IIa HDACs to develop two generations of new compounds that are potent and selective inhibitors of class IIa HDACs.

By The University of Queensland

Reference Number 08993

Last Update May 27, 2022

Published

Healthcare & Pharmaceuticals

C3a Receptor Modulators

University of Queensland researchers have developed series of novel, potent and selective, small organic molecules that mimic C3a (agonists) or inhibit its action (antagonists)

By The University of Queensland

Reference Number 09029

Last Update May 30, 2022